New review! #GLP-1 receptor agonists and serious adverse events.
➡️ Appraises evidence regarding seven serious adverse events linked to GLP-1 receptor agonists.
➡️ Evidence, uncertainty and clinical implications.
🔗 doi.org/10.1111/joim.70170
#diabetesmellitus #obesity